citat
macparland
sa
xz
chen
l
khattar
r
cherepanov
v
selzner
feld
jj
selzner
n
mcgilvray
id
lipopolysaccharid
tumor
necrosi
factor
alpha
inhibit
interferon
signal
hepatocyt
increas
ubiquitinlik
proteas
express
j
virol
nterferon
ifn
key
endogen
mediat
viral
clearanc
innat
immun
respons
one
excel
exampl
hepat
c
viru
hcv
infect
liver
interferon
signal
drive
express
multipl
interferonstimul
gene
isg
mediat
viral
clearanc
isg
howev
also
induc
factor
includ
inflammatori
stimuli
tumor
necrosi
factor
alpha
hcv
infect
induc
chronic
inflamm
liver
associ
high
serum
interestingli
treatment
shown
lead
improv
virolog
respons
antivir
therapi
hcv
data
show
safeti
combin
treatment
effect
hcv
viral
load
hcv
treatmentna
individu
purpos
present
studi
defin
import
causal
link
inflamm
host
hepat
innat
immun
respons
broad
viral
relev
recent
work
host
innat
immun
respons
chronic
hcv
infect
suggest
associ
hepatocyt
liver
resid
immun
cell
drive
liver
inflamm
dichotom
respons
chronic
hcv
infect
liver
respons
predict
respond
exogen
treatment
patient
respond
therapi
ifnribavirin
hepatocyt
strong
preactiv
ifnrespons
high
express
subset
isg
patient
exhibit
sustain
virolog
respons
therapi
ifnribavirin
tissu
macrophag
show
high
express
isg
express
isg
macrophag
hepatocyt
predict
treatment
outcom
polymorph
find
suggest
link
hepat
inflammatori
cell
activ
viral
clearanc
liver
kupffer
cell
inflammatori
respons
induc
play
role
control
clearanc
multipl
viral
infect
liver
although
mechan
underli
pattern
undoubtedli
complex
associ
liver
macrophag
hepatocyt
rais
question
hepatocyt
react
cytokin
produc
macrophag
inflammatori
cell
isg
express
hepatocyt
reflect
respons
inflammatori
stimuli
liver
respond
viral
infect
modul
inflammatori
milieu
hcv
infect
found
pathway
import
regulatori
pathway
isg
strongli
upregul
liver
ifn
treatmentresist
patient
ubiquitinlik
protein
strongli
upregul
ifn
conjug
multipl
cellular
protein
proteas
also
upregul
suggest
blunt
type
ifn
signal
addit
abil
remov
conjug
protein
shown
bind
type
ifn
receptor
blunt
ifn
signal
upregul
may
repres
negativefeedback
loop
counteract
effect
type
ifn
furthermor
knockdown
increas
isg
induct
antihcv
activ
data
shown
treatment
given
mice
vivo
increas
hepat
blunt
effect
subsequ
dose
mechan
control
express
liver
poorli
understood
relev
understand
innat
immun
mechan
chronic
viral
infect
although
major
work
center
upregul
type
ifn
interferon
stimul
gene
multipl
upregulatori
stimuli
exampl
inflammatori
stimuli
eg
endotoxin
lipopolysaccharid
lp
shown
upregul
periton
exud
macrophag
similar
stimuli
lead
increas
express
hepatocyt
pathway
could
repres
novel
link
inflammatori
innat
immun
respons
liver
present
studi
base
hypothesi
liver
inflamm
directli
impact
hepatocyt
express
therefor
impact
ifn
signal
link
relev
multipl
diseas
sinc
inflammatori
stimuli
lp
shown
play
role
mani
liver
diseas
includ
viral
hepat
link
may
also
help
explain
observ
chronic
hcv
infect
sinc
chronic
hcv
infect
character
increas
serum
increas
hepatocyt
impair
ifn
respons
quit
apart
hcv
import
link
hepat
inflamm
innat
immun
respons
lie
downstream
effect
impair
innat
immun
specul
block
signal
express
may
lead
enhanc
suscept
infect
interferonsensit
virus
enhanc
viral
prolifer
support
notion
found
mous
studi
express
macrophag
led
lower
ifn
respons
lead
local
restrict
replic
vsv
present
studi
treatment
hepat
cell
lp
led
upregul
express
hepatocyt
enhanc
express
associ
decreas
express
isg
phenomenon
revers
knockdown
vivo
correl
vitro
find
experiment
induc
hepat
ischemiareperfus
injuri
induc
mrna
express
liver
enhanc
lymphocyt
choriomening
lcmv
replic
effect
seen
mice
data
demonstr
certain
inflammatori
stimuli
lp
well
ischem
injuri
cytokin
lead
enhanc
hepatocyt
express
therebi
inhibit
ifn
signal
find
lend
new
knowledg
understand
inflamm
modul
hepat
innat
immun
respons
repres
potenti
target
intervent
revers
provir
effect
inflamm
cell
signal
technolog
boston
rabbit
polyclon
santa
cruz
biotechnolog
goat
polyclon
antibodi
santa
cruz
biotechnolog
mous
monoclon
antiactin
sigma
antibodi
follow
antimous
antirabbit
igg
conjug
horseradish
peroxidas
calbiochem
billerica
enhanc
chemiluminesc
detect
kit
amersham
pharmacia
biotech
uppsala
sweden
use
determin
level
protein
express
flow
cytometr
quantif
express
cell
express
cell
treat
lp
tnf
quantifi
use
flow
cytometri
previous
describ
briefli
cell
fix
permeabil
stain
mous
antihuman
polyclon
antibodi
abnova
relev
isotypematch
control
antibodi
stain
detect
secondari
goat
antimous
igg
label
fluorescein
isothiocyan
fitc
santa
cruz
biotechnolog
cell
acquir
use
facscalibur
cytomet
bd
bioscienc
san
jose
ca
minimum
event
collect
result
data
analyz
use
flowjo
softwar
tree
star
inc
experi
repeat
four
time
sirna
target
murin
small
interf
rna
sirna
pool
three
targetspecif
nt
sirna
design
knock
gene
express
obtain
santa
cruz
biotechnolog
sirna
use
pool
three
five
targetspecif
sirna
design
knockdown
mous
gene
express
obtain
santa
cruz
sirna
transfect
primari
murin
hepatocyt
accord
manufactur
instruct
use
santa
cruz
sirna
reagent
system
santa
cruz
previous
describ
inhibit
inflammatori
signal
primari
mous
hepatocyt
inhibit
lpsor
nfb
activ
primari
mous
hepatocyt
incub
follow
inhibitor
min
prior
h
stimul
lp
protein
kinas
inhibitor
inhibitor
protein
kinas
c
inhibitor
mitogenactiv
protein
kinas
kinas
inhibitor
silibinin
inhibitor
wortmannin
phosphatidylinositid
inhibitor
concentr
sourc
main
target
inhibitor
describ
tabl
lp
stimul
hepatocyt
harvest
surrog
nfb
activ
mrna
express
evalu
describ
rna
isol
quantit
realtim
pcr
analysi
cell
primari
murin
hepatocyt
treat
uml
ngml
lp
ngml
ngml
ng
ml
time
cours
express
determin
quantit
pcr
qpcr
previous
describ
briefli
total
rna
prepar
cell
use
trizol
reagent
invitrogen
accord
manufactur
instruct
revers
transcript
reaction
extract
rna
perform
firststrand
cdna
synthesi
kit
amersham
pharmacia
biotech
accord
manufactur
direct
first
g
extract
rna
ad
total
volum
l
combin
cdna
reaction
reagent
random
hexam
oligonucleotid
firststrand
primer
reaction
tube
sampl
heat
min
chill
ice
min
incub
h
follow
incub
specif
primer
detect
gene
pcr
base
genbankpublish
sequenc
mu
musculu
ubiquitinspecif
peptidas
forward
primer
revers
primer
mu
musculu
myxoviru
influenza
viru
resist
forward
primer
revers
primer
mous
hypoxanthin
guanin
phosphoribosyltransferas
hprt
forward
primer
caacgggggacataaa
revers
primer
tgcttaaccag
mu
musculu
forward
primer
revers
primer
atgctctcatcaggacag
homo
sapien
forward
primer
revers
primer
homo
sapien
ifng
forward
primer
tcca
revers
primer
homo
sapien
actin
betalik
forward
primer
revers
primer
acgccctatcatgg
homo
sapien
ubiquitin
specif
peptidas
forward
primer
tcca
revers
primer
homo
sapien
myxoviru
influenza
viru
forward
primer
revers
primer
quantit
realtim
pcr
perform
abi
prism
machin
appli
biosystem
foster
citi
ca
sybr
green
realtim
pcr
master
mix
appli
biosystem
accord
direct
provid
manufactur
rna
sampl
control
assay
duplic
realtim
pcr
condit
follow
min
follow
cycl
monitor
fluoresc
sybr
channel
annealingextens
step
result
analyz
use
appli
biosystem
softwar
appli
biosystem
experiment
hepat
ischemiareperfus
injuri
model
hepat
ischemiareperfus
injuri
hiri
simul
partial
hepat
ischemia
induc
min
mice
surgic
clamp
remov
control
sham
anim
underw
anesthesia
laparotomi
alon
anim
euthan
h
ischemiareperfus
affect
liver
segment
remov
target
gene
express
determin
qpcr
whole
liver
tissu
lcmv
strain
propag
cell
atcc
previous
describ
addit
experi
min
hiri
sham
laparotomi
mice
infect
pfu
lcmv
intraven
tail
vein
inject
ischem
liver
lobe
harvest
day
postinfect
snapfrozen
liver
tissu
sampl
homogen
multicel
usa
supplement
fb
lglutamin
u
penicillinml
plu
g
streptomycinml
use
tissuelys
lt
system
qiagen
netherland
viral
titer
examin
cell
atcc
use
focusform
assay
previous
describ
statist
analysi
data
analyz
use
prism
version
softwar
graphpad
softwar
san
diego
ca
statist
signific
differ
fig
calcul
use
twotail
student
test
prism
softwar
impact
hiri
lcmv
replic
see
fig
b
evalu
oneway
analysi
varianc
tukey
post
hoc
test
induc
hepatocyt
lp
previous
shown
modul
type
ifn
respons
sought
determin
whether
inflammatori
stimuli
could
increas
express
hepatocyt
liver
tissu
inflamm
mediat
proand
antiinflammatori
stimuli
act
divers
pathway
therefor
compar
effect
three
proinflammatori
stimuli
lp
one
antiinflammatori
stimulu
four
signal
independ
receptor
signal
cascad
time
cours
experi
mrna
express
measur
stimul
lp
ngml
ngml
ngml
ngml
mrna
express
induc
lp
fig
meanwhil
neither
lp
treatment
mark
effect
mrna
express
fig
indic
effect
observ
due
gener
upregul
isg
type
ifn
signal
lp
treatment
also
led
augment
protein
express
western
blot
fig
intracellular
stain
fig
f
treatment
cell
lp
induc
express
respect
compar
untreat
control
express
fig
induct
also
demonstr
signific
shift
mean
fluoresc
intens
stain
lp
simul
fig
assay
degre
protein
express
correl
complet
mrna
express
find
consist
mani
gene
liver
degre
mrna
induct
higher
observ
protein
express
howev
function
effect
observ
term
respons
robust
lp
block
signal
hepatoma
cell
determin
whether
inflammatori
stimuli
lp
interfer
type
ifn
signal
sought
determin
whether
pretreat
hepatoma
cell
lp
block
signal
cell
treat
ngml
lp
ngml
h
cell
subsequ
treat
h
chose
h
measur
express
base
previou
descript
ifnstimul
induct
literatur
base
observ
primari
mous
hepatocyt
control
cell
left
untreat
follow
treatment
h
treatment
cell
harvest
express
measur
qpcr
measur
ifninduc
gene
express
expect
exposur
strongli
induc
express
wherea
exposur
lp
fig
column
lp
pretreat
inhibit
effect
h
exposur
fig
column
indic
signal
impair
presenc
inflammatori
stimuli
shown
certain
inflammatori
stimuli
increas
hepatocyt
blunt
signal
next
sought
determin
whether
blunt
signal
mediat
via
increas
address
question
select
knockdown
mrna
thu
cell
transfect
sirna
control
sirna
treat
lp
ngml
ngml
andor
iuml
h
pretreat
lp
ngml
ngml
h
either
left
untreat
treat
iuml
h
time
point
select
optim
express
cell
express
conjug
marker
knockdown
actin
detect
western
blot
seen
fig
express
larg
knock
cell
transfect
sirna
phosphoryl
inhibit
pretreat
h
lp
fig
sirna
control
lane
f
h
versu
lane
effect
revers
knockdown
fig
sirna
lane
f
h
versu
lane
note
knockdown
increas
respons
h
find
consist
previou
observ
next
want
confirm
whether
find
hepatoma
cell
would
hold
true
primari
mous
hepatocyt
mind
primari
murin
hepatocyt
mice
isol
transfect
sirna
control
sirna
expos
iuml
lp
ngml
ngml
h
wash
step
cell
treat
addit
h
isg
mrna
express
measur
qpcr
normal
express
hprt
housekeep
gene
index
downstream
effect
lp
treatment
block
effect
final
dose
fig
column
howev
knockdown
revers
effect
augment
effect
fig
column
data
experi
consist
obtain
human
cell
data
shown
thu
abil
lp
block
ifn
signal
seen
primari
immort
hepatocyt
note
earlier
dual
role
strip
target
protein
impair
type
ifn
signal
independ
proteas
activ
determin
whether
blunt
hepatocyt
ifn
signal
due
abil
strip
conjug
block
process
isgyl
knockdown
enzym
murin
hepatocyt
knock
via
transfect
sirna
specif
murin
hepatocyt
transfect
sirna
control
sirna
stimul
iuml
lp
ngml
ngml
h
treat
addit
dose
h
knockdown
measur
hepatocyt
transfect
sirna
western
blot
probe
express
conjug
format
fig
next
examin
effect
knockdown
isg
induct
wildtyp
murin
hepatocyt
transfect
sirna
control
sirna
stimul
ngml
lp
ngml
h
restimul
iu
ml
h
time
isg
mrna
express
measur
qpcr
seen
fig
knockdown
achiev
result
decreas
conjug
howev
seen
fig
observ
neither
presenc
rel
absenc
conjug
impact
abil
lp
block
signal
sinc
chang
isg
express
h
treatment
hepatocyt
transfect
sirna
compar
hepatocyt
transfect
irrelev
sirna
fig
sirna
control
column
sirna
column
result
consist
role
isgyl
thu
abil
strip
protein
conjug
abil
lp
block
type
ifn
signal
hepatocyt
find
agreement
previou
data
show
block
ifn
signal
independ
enzymat
activ
next
sought
determin
whether
lp
could
induc
express
hepatocyt
via
induct
observ
fig
phosphoryl
show
distinct
activ
profil
stimul
compar
lp
stimul
fig
sirna
control
sirna
lane
b
c
compar
lane
although
data
strongli
suggest
effect
lp
stimul
result
direct
induct
isg
secondari
induct
want
confirm
whether
lp
could
induc
type
type
ifn
primari
murin
hepatocyt
thu
primari
murin
hepatocyt
treat
lp
ngml
ngml
h
lyse
assess
express
qpcr
observ
neither
lp
induc
much
hepatocyt
express
although
dose
induc
strong
express
fig
thu
induct
isg
lp
unlik
reflect
induct
hepatocyt
type
type
ifn
suggest
observ
induct
due
type
type
ifn
secret
autocrin
stimul
receptor
experiment
hepat
ischemiareperfus
induc
express
enhanc
lcmv
replic
assess
whether
tissuewid
hepat
inflammatori
stress
increas
liver
express
vivo
confirm
vitro
find
approach
induc
partial
hepat
ischemiareperfus
injuri
hiri
min
mice
euthan
anim
h
time
point
relev
vitro
time
cours
measur
induct
qpcr
chose
hiri
wellcharacter
inflammatori
stress
known
driven
lp
seen
fig
hiri
alon
induc
mrna
express
whole
liver
untreat
anim
thu
vivo
liver
inflamm
lead
increas
express
organ
level
determin
hiri
induc
express
next
want
examin
impact
hiri
viral
control
thu
induc
hiri
min
prior
lcmv
infect
mice
seen
fig
hiri
led
signific
increas
lcmv
viral
titer
mice
effect
observ
mice
shown
lp
stimul
increas
hepatocyt
express
sought
determin
whether
could
pharmacolog
inhibit
induct
lp
focus
smallmolecul
agent
link
nfb
signal
pathway
central
role
pathway
inflammatori
activ
respons
larg
number
inflammatori
mediat
includ
lp
particularli
interest
inhibitor
silibinin
addit
link
clinic
suppress
hepat
viral
product
case
silibinin
hcv
thu
preincub
primari
mous
hepatocyt
min
variou
inhibitor
lp
signal
measur
impact
induct
simultan
measur
express
proinflammatori
cytokin
mrna
sinc
nfb
also
known
promot
transcript
seen
fig
tabl
induc
express
potent
downregul
inhibitor
test
inhibit
coincid
impair
mrna
express
fig
meanwhil
two
inhibitor
potent
inhibit
express
well
mrna
express
respons
lp
stimul
inhibitor
silibinin
inhibitor
fig
b
tabl
data
suggest
induct
lp
possibl
inflammatori
stimuli
promot
signal
hepatocyt
express
particularcompar
attract
target
pharmacolog
manipul
set
liver
inflamm
studi
examin
role
variou
inflammatori
stimuli
induct
downstream
establish
inflammatori
stimuli
examin
induct
phosphoryl
cell
without
knockdown
express
isg
mrna
primari
mous
hepatocyt
abil
knockdown
restor
isg
induct
lp
stimul
b
cell
transfect
sirna
control
irrelev
sirna
cell
pretreat
lp
ngml
ngml
uml
left
untreat
h
expos
left
untreat
addit
h
control
cell
treat
lp
h
express
conjug
actin
protein
measur
western
blot
b
primari
murin
hepatocyt
mice
isol
transfect
sirna
control
irrelev
sirna
pretreat
iuml
lp
ngml
ngml
h
pre
lp
pre
pre
respect
wash
cell
cultur
presenc
absenc
h
final
isg
mrna
express
measur
qpcr
normal
express
hprt
housekeep
gene
data
gener
pool
triplic
experi
analyz
duplic
error
bar
repres
sem
duplic
pcr
refractori
state
use
multipl
method
show
certain
inflammatori
stimuli
includ
lp
abl
induc
express
result
downstream
downregul
isg
express
role
refractori
state
previous
demonstr
human
mous
knockdown
studi
inflammatori
stimuli
includ
induc
impair
express
isg
includ
vivo
hepat
inflammatori
stress
ischemiareperfus
injuri
led
increas
hepat
gene
express
associ
poor
control
lcmv
infect
thu
hepat
inflammatori
milieu
contribut
individu
inflammatori
cytokin
stimuli
modul
express
result
demonstr
one
mechan
liver
inflamm
directli
impact
hepatocellular
innat
immun
respons
known
induc
multipl
inflammatori
stimuli
macrophag
lymphocyt
find
hepatocyt
consist
work
done
group
immun
cell
exampl
lp
treatment
murin
macro
phage
cell
line
upregul
manner
cytokin
specif
result
also
consist
find
alon
abl
induc
murin
cell
cell
treat
anoth
proinflammatori
cytokin
transform
growth
factor
express
induc
data
point
induc
inflammatori
stimuli
multipl
cell
type
absenc
ifn
therefor
well
posit
act
mediat
cross
talk
innat
immun
inflammatori
respons
present
studi
show
increas
express
follow
exposur
hepatocyt
inflammatori
stimuli
blunt
ifn
respons
bind
receptor
shown
inhibit
interact
receptor
thu
block
downstream
ifn
signal
data
consist
mechan
sinc
blunt
hepatocyt
ifn
signal
exposur
inflammatori
stimuli
independ
remov
target
protein
degre
lpsinduc
refractori
chang
knockdown
although
isgyl
consider
reduc
howev
mechan
may
also
play
recent
work
demonstr
abil
deubiquitin
transform
growth
factoractiv
kinas
complex
requir
nfb
activ
cell
overexpress
lead
decreas
nuclear
activ
impair
format
complex
nfb
inhibit
may
import
cell
adapt
immun
also
liver
inflamm
role
innat
adapt
immun
previous
demonstr
studi
also
shown
delet
interfer
hepatocyt
homeostasi
lead
hepat
injuri
thu
increas
hepatocyt
respons
inflammatori
stimuli
may
constitut
negativefeedback
cycl
relev
multipl
aspect
liver
respons
infect
vivo
experi
demonstr
inflamm
result
ischemiareperfus
injuri
induc
express
coincid
diminish
lcmv
control
mous
liver
gener
find
liver
inflamm
promot
lcmv
product
agreement
work
show
polymicrobi
sepsi
character
high
inflamm
lead
increas
suscept
lcmv
infect
present
studi
hepat
ischemiareperfus
injuri
enhanc
lcmv
product
knockout
mice
data
intend
proofofconcept
suggest
role
hepat
viral
infect
inflamm
deserv
investig
vitro
vivo
find
suggest
new
model
inflamm
alter
hepat
innat
immun
respons
model
liver
inflamm
lead
increas
hepatocyt
turn
make
liver
suscept
infect
target
hepatocyt
hcv
mechan
may
help
explain
clinic
observ
hcv
infect
transplant
hcvnaiv
liver
graft
gone
ischemiareperfus
cycl
aggress
origin
infect
sever
reinfect
correl
sever
ischemiareperfus
injuri
suffer
transplant
howev
also
found
necessari
suffici
induc
refractori
state
mind
hypothes
innat
immun
respons
abil
control
ifnsensit
virus
depend
cumul
effect
multipl
intrahepat
signal
includ
induct
result
translat
clinic
set
one
approach
target
induct
pharmacolog
use
multipl
inhibitor
signal
found
two
inhibitor
silibinin
inhibitor
inhibitor
possess
abil
inhibit
lpsinduc
express
proinflammatori
effect
find
rais
possibl
pharmacolog
target
express
inflammatori
event
prevent
establish
refractori
state
previous
inhibit
signal
led
protect
mous
liver
ischem
insult
well
silibinin
shown
reduc
hcv
liver
graft
reinfect
enhanc
hcv
clearanc
nonrespond
via
multipl
mechan
includ
direct
inhibit
hcv
rna
polymeras
modul
may
one
mechan
silibinin
exert
antihcv
effect
present
studi
focus
rel
small
number
inflammatori
stimuli
lp
import
larg
number
liver
diseas
far
driver
hepat
inflammatori
respons
tissu
level
like
influenc
stimuli
well
exampl
previous
demonstr
increas
express
liver
enhanc
lcmv
replic
examin
vivo
effect
inflammatori
stimulu
express
viral
replic
hepat
ischemiareperfus
model
use
partial
hepat
ischemia
induc
min
portal
vascular
clamp
remov
control
anim
sham
underw
anesthesia
laparotomi
alon
anim
euthan
h
ischemiareperfus
ir
affect
liver
segment
remov
mrna
express
determin
qpcr
whole
liver
tissu
normal
hypoxanthineguanin
phosphoribosyltransferas
hprt
express
data
express
mean
sem
n
micegroup
p
valu
consid
signific
b
min
hiri
sham
laparotomi
mice
infect
pfu
lcmv
liver
lobe
harvest
day
postinfect
viral
titer
examin
cell
use
focusform
assay
data
express
mean
sem
n
micegroup
p
valu
consid
signific
inhibit
nfb
activ
impair
lpsand
induct
investig
link
stimul
induct
inhibitor
nfb
activ
ad
primari
mous
hepatocyt
min
prior
stimul
ng
ng
lpsml
h
inhibitor
name
target
concentr
use
given
tabl
inhibitortr
cell
also
left
unstimul
control
control
induct
hepatocyt
stimul
u
h
b
mrna
express
level
evalu
pcr
normal
hprt
housekeep
gene
express
prior
determin
fold
increas
versu
mocktreat
sampl
data
gener
pool
triplic
experi
analyz
duplic
error
bar
repres
sem
duplic
pcr
predict
patient
chronic
hcv
infect
respond
ifnbas
antihcv
therapi
although
found
hepat
mrna
express
increas
treatment
nonrespond
rel
increas
treatment
respond
suspect
wherea
increas
contribut
express
stimuli
exampl
lp
perhap
recent
describ
interferonlambda
also
modul
hepat
express
propos
ultim
express
due
liver
coordin
respons
multipl
stimuli
find
hepat
express
modul
inflammatori
stimuli
new
paradigm
interact
liver
inflammatori
microenviron
viral
infect
taken
togeth
data
may
suggest
repres
good
target
intervent
numer
inflammatori
state
clinic
set
hcvrelat
liver
transplant
hiriinduc
upregul
could
lead
worsen
outcom
posttranspl
includ
quicker
aggress
reinfect
new
organ
higher
hcv
rna
titer
suggest
find
ifn
respons
express
tightli
link
hepat
inflammatori
respons
help
explain
find
antibodi
treatment
improv
treatment
outcom
chronic
hcv
treatment
combin
includ
